Jessica D. Jensen - Apr 1, 2022 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
EVP Clinical Development
Signature
/s/ William L. Demers, by Power of Attorney for Jessica D. Jensen
Stock symbol
PNT
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
4
Date filed
4/5/2022, 10:48 AM
Previous filing
Mar 31, 2022
Next filing
Mar 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +13.8K $0.00 13.8K Apr 1, 2022 Common Stock 13.8K $7.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter.